Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Innovation Not Forgotten Art For Device Conglomerates - Wharton Panel

This article was originally published in The Gray Sheet

Executive Summary

Large device companies play a significant role in medical technology innovation, contrary to the somewhat widespread belief that the start-up sector is the primary driver of R&D, Boston Scientific Chairman Peter Nicholas maintained.

You may also be interested in...



Reimbursement Tops List Of Venture Capital Concern Over Device Start-Ups

The low number of first-round venture capital (VC) deals in 1999 among medical device start-ups is cause for concern, according Casey McGlynn, of the Silicon Valleuy law firm Wilson Sonsini Goodrich & Rosati.

Boston Scientific Buyouts Grow R&D, Offer Liquid Exit For Device Start-Ups

Boston Scientific's strategy to engage emerging medical device companies in a variety of collaborative arrangements provides the company an important source of R&D as well as an attractive exit strategy for the device start-ups, according to Frank Grillo, director of new business development.

Real World Data Failed To Impress Kaftrio’s European Reviewers

The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.

UsernamePublicRestriction

Register

LL018264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel